Hepatitis A vaccine (human diploid cell),inactivated (Aimekanghuai Biopharmaceutical)

甲型肝炎灭活疫苗(人二倍体细胞)（艾美康淮）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A vaccine (human diploid cell),inactivated (Aimekanghuai Biopharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis A

Global Approved IndicationsHepatitis A

Approved Indications in ChinaHepatitis A

Original Approved Country/TerritoryMainland China

Original Approved Date2003/06/13

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesAimei Convac BioPharm (Jiangsu) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Convac BioPharm (Jiangsu) Co Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis A

Inactive IndicationsN/A

Other Information

ATC CodeJ07BC02